← Back to Search

Procedure

Laser Treatment for Basal Cell Carcinoma

N/A

Recruiting

Led By Christopher Zachary, MBBS FRCP

Research Sponsored by University of California, Irvine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ages 18 and older

Seeks and is scheduled for treatment of a BCC previously confirmed with biopsy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial showed that laser treatment of basal cell carcinoma was more effective when guided by optical coherence tomography.

Who is the study for?

This trial is for adults over 18 with a confirmed diagnosis of basal cell carcinoma (BCC) who are seeking treatment and can follow instructions or have someone to help them. It's not for pregnant individuals, those unable to commit to a full year of follow-up, patients with BCCs on legs or near the eyes, or cases where the cancer is too large, deep, high-risk or has spread.Check my eligibility

What is being tested?

The study tests how well a type of laser called the 1064 nm long-pulse Nd:YAG can treat basal cell carcinoma when guided by optical coherence tomography—a technique that uses light waves to take cross-section pictures of skin.See study design

What are the potential side effects?

While specific side effects aren't listed here, laser treatments may generally include redness, swelling at the treatment site, discomfort during the procedure, potential burns or blisters if not done correctly and changes in skin pigmentation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am scheduled for treatment of a biopsy-confirmed basal cell carcinoma.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Complete clearance of BCC lesion

Secondary outcome measures

Cosmetic outcome

Trial Design

2Treatment groups

Active Control

Group I: StandardActive Control1 Intervention

1064 Long-pulse Nd:YAG laser Fluence: 120 J/cm2 Number of passes: Single Spot size: 2 cm Pulse width: 8-10 msec

Group II: SlowActive Control1 Intervention

1064 Long-pulse Nd:YAG laser Fluence: 20-30 J/cm2 Number of passes: Multiple Spot size: 2 cm Pulse width: 8-10 msec

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, IrvineLead Sponsor

544 Previous Clinical Trials

1,923,003 Total Patients Enrolled

Christopher ZacharyLead Sponsor

Christopher Zachary, MBBS FRCPPrincipal InvestigatorUniversity of California, Irvine

Media Library

Optical Coherence Tomography Guided Laser Treatment (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04744935 — N/A

Basal Cell Carcinoma Research Study Groups: Standard, Slow

Basal Cell Carcinoma Clinical Trial 2023: Optical Coherence Tomography Guided Laser Treatment Highlights & Side Effects. Trial Name: NCT04744935 — N/A

Optical Coherence Tomography Guided Laser Treatment (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04744935 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being enrolled into this research project?

"Correct. The clinicaltrials.gov website states that this research is presently recruiting participants, which was initially posted on the 13th of January 2021 and last updated on 4th February. 40 people are being sought for enrollment in 2 separate medical sites."

Answered by AI

Who can sign up to participate in this clinical experiment?

"This research is searching for 40 volunteers, between 18 and 99 years of age, currently living with carcinoma. The eligibility criteria also necessitate that applicants must comprehend the instructions or have a legal guardian/representative to do so on their behalf."

Answered by AI

What is the scope of this experiment in terms of participants?

"Affirmative. According to clinicaltrials.gov, this health study is currently recruiting potential participants and was first made available on January 13 2021; its most recent update being February 4th of the same year. At present, it needs 40 people from 2 sites for completion."

Answered by AI

Are adults above the age of 20 eligible to be enrolled in this medical experiment?

"To participate in this trial, individuals must be between 18 and 99 years old. Alternatively, there are 75 trials designed for minors and 2459 studies specifically conducted with elderly patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma

Christopher Zachary 2021. "Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04744935.